February 7, 2020
The Week’s Biggest Winner & Loser
GW Pharma (GWPH)
Following reports that GW Pharma’s (GWPH) blockbuster epilepsy drug is even more of a blockbuster than anyone thought, GWPH jumped +9.63% to notch this week’s Biggest Winner spot.
Canopy Growth (CGC)
… and on the other side of the cannabis coin, Canopy Growth Corp (CGC) got slammed for -12.95% after Aurora Cannabis (ACB) reported a dismal quarter – so bad the CEO resigned – due to continued troubles in the consumer cannabis space.
In a week where almost everything rebounded from last week’s sell-off, CGC definitely landed the spot of the week’s Biggest Loser.
Target Position Size
Current Position Performance
1st Buy 2/14/2012 @ $79.58
Current Per-Share: (-$624.66)*
1st Buy 4/18/2013 @ $56.38
Current Per-Share: (-$158.51)*
1st Buy 8/5/2016 @ $11.10
Current Per-Share: (-$43.58)*
1st Buy 2/14/2012 @ $26.71
Current Per-Share: (-$54.91)*
1st Buy 2/14/2012 @ $41.70
Current Per-Share: (-$6.43)*
1st Buy 9/6/2016 @ $63.10
Current Per-Share: (-$46.12)*
IDEXX Lab (IDXX)
1st Buy 7/26/2017 @ $167.29
Current Per-Share: $116.86
JP Morgan (JPM)
1st Buy 10/26/2017 @ $102.30
Current Per-Share: $90.41
1st Buy 11/11/2016 @ $24.20
Current Per-Share: $32.02
1st Buy 10/26/2017 @ $74.06
Current Per-Share: $56.80
GW Pharm (GWPH)
1st Buy 7/25/2018 @ $142.28
Current Per-Share: $118.92
1st Buy 5/24/2018 @ $29.53
Current Per-Share: $18.94
1st Buy 5/13/2019 @ $53.18
Current Per-Share: $47.03
1st Buy 1/31/2020 @ $113.60
Current Per-Share: $114.37
* Indicates a position where the capital investment was sold.
Profit % for * positions = Total Profit / Original Capital Investment
This Week’s Moves
Canopy Growth Corp (CGC): Added to Position
I added to Canopy Growth Corporation (CGC) on Friday when it started to show weakness with buy orders which filled at an average price of $19.70.
The orders replace shares I sold in from November-December with an average price of $20.32, locking in a relatively minor 3.05% in profits. However, the orders also allowed me to capitalize on potential in the sector. The order increased my per-share cost by 1.23% from $18.71 to $18.94.
Thanks to the elimination of many positions from the portfolio over the past several months, my allocation targets have increased substantially which allows me to be more aggressive in accumulating more of my remaining positions.
My next buy for CGC is targeting a $17.80-$18.10 price target with no sell targets on the position at this time.
CGC closed the week at $19.63, down -0.36% from Friday’s average buy.
Logitech (LOGI): Added to Position
Although the markets popped on Monday, I realized I wanted to add to my Logitech (LOGI) position after selling some shares too soon back in December at $45.31. Using a stop-limit buy order, I replaced those shares at $44.91, a reduction in price of just -0.88%, however, with the elimination of many positions, my plan is to add to my existing positions a little more aggressively.
Monday’s buy raised my per-share cost by 0.95% from $31.72 to $32.02.
My next buy target for Logitech is $44.00.
LOGI closed the week at $45.12, up +0.47% from where I added Monday.
Skyworks Solutions (SWKS): Added to Position
After watching Skyworks Solutions’ (SWKS) incredible resiliency following last week’s sell-off during this week’s rally, I realized I was far too conservative with my initial opening buy.
So, when SWKS sold off on Friday, I “doubled” my position with an order which filled at $115.14. The order increased my per-share cost +0.68% from $113.60 to $114.37 but still leaves me with only about 10% of my maximum target allocation. My next buy target range is at $110.95-111.15.
SWKS closed the week at $113.94, down -1.04% from where I added Friday.
Want Further Clarification?
As always, if you have questions about any of my positions or have positions of your own that you’re curious about – feel free to leave a comment below!
See you next week!